DRUGSwww.epgonline.orgDISEASE KNOWLEDGE CENTRESwww.epgonline.orgGUIDELINESwww.epgonline.orgCLINICAL TRIALSwww.epgonline.orgMEDICAL NEWSwww.epgonline.orgLINKSwww.epgonline.org
Members Login
How to use the
Email

Password



EPG News Feed Medical News Feed
EPG Online Disease Knowledge Centres Feed Knowledge Centres Feed
EPG Search
Frequent Searches:
Search
Languages

Browse Other Languages
YouTube - Featured Content

Want to submit or suggest content for the epgonline.org YouTube Clinical channel?
Contact us here

epgonline.org is not responsible for content on any 3rd party website

Men's Health - understanding, management, diagnosis and treatment information Benign prostatic hyperplasia (BPH) - understanding, management, diagnosis and treatment information Parkinson's Disease - understanding, management, diagnosis and treatment information. Medical conferences for the Healthcare professional
Are you a Doctor or Healthcare Professional? Authorise Viewing

Please register to access disease diagnosis, patient management, physician tools.

By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.

Change language Current language database: United Kingdom

A  |  B  |  C  |  D  |  E  |  F  |  G  |  H  |  I  |  J  |  K  |  L  |  M
N  |  O  |  P  |  Q  |  R  |  S  |  T  |  U  |  V  |  W  |  X  |  Y  |  Z

Drug details for : XALATAN
 
Drug class description :  Prostaglandin analogues.
Generic Name :  Latanoprost
Drug description :  Eye drops.
Presentation :  Eye drops, latanoprost 50 microgram per mL.
Indications :  Open angle glaucoma and ocular hypertension where other treatments have failed or are not tolerated.
Adult Dosage :  1 drop in affected eye(s) once daily, preferably in the evening.
Child Dosage :  Not recommended.
Contra Indications :  Contact lenses. Pregnancy, lactation.
Special Precautions :  Inflammatory, neovascular, angle closure or congenital glaucoma, pigmentary glaucoma, open angle glaucoma in pseudophakic patients. Severe asthma. Aphakic patients, pseudophakic patients with torn posterior lens capsule or anterior chamber lenses. Patients with known risk factors for cystoid macular oedema.
Interactions :  Leave interval of at least 5 minutes with other topical eye preparations. preparations.
Adverse Reactions :  Darkening of mixed coloured irides; inform patient. Darker, longer or thicker lashes. Blurred vision, conjunctival hyperaemia, foreign body sensation, transient punctate epithelial erosion. Periorbital oedema. Rarely, macular oedema, iritis, uveitis, corneal oedema, asthma exacerbation, dyspnoea. Very rarely, darkening of palpebral skin.
Manufacturer :  Pharmacia & Upjohn
Drug Availability :  (POM)
Free registration to access disease diagnosis, patient management, physician tools.

Only registered users have access to the full EPG Online Knowledge Base including drug search tools, interactive disease Knowledge Centres via the EPG Knowledge Library - with clinical and evidence based physician and research tools, MiMedia (build your own clinical media collection with everything from key opinion leader essays to mode of action videos and other multi-media content), the EPG Survey panel, health news updates and much much more.

Already Registered?

Please log-in now using our member login box.

Not a member?

Don't worry, registration is quick and FREE! We welcome all Healthcare professionals, doctors, nurses and medical students.

Register today to have full access to a wealth of drug data, educational and evidence based interactive guides across all major therapeutic areas, disease management, and clinical tools.

As a practicing Healthcare professional, you can also opt-in to join our market research panel – www.epgsurvey.com – and get paid for sharing your expert clinical opinions!

REGISTER today it only takes a minute! and it's FREE

Having problems?

Use our forgotten password facility or email us at: contact@epgonline.org

What's New!
Try EPG Mobile
Latest News
Disease Knowledge Centres

EPG Survey Become a member of
the new EPG Survey Panel.
Your opinions matter, get paid for them! Join Now!